Literature DB >> 17536841

Dual-specificity tyrosine phosphorylation-regulated kinase 1A does not require tyrosine phosphorylation for activity in vitro.

Tatyana Adayev1, Mo-Chou Chen-Hwang, Noriko Murakami, Eric Lee, David C Bolton, Yu-Wen Hwang.   

Abstract

The dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) gene is localized in human chromosome 21, and its overexpression has been associated with the learning and memory deficits of Down syndrome. DYRK1A contains a Y319XY321 motif shared by all members of the DYRK protein kinase family. Residue Y321 in the motif is phosphorylated in DYRK1A prepared from Escherichia coli and from eukaryotic cells. It has been proposed that the YXY motif is an equivalent of the TXY motif, the activation loop, of mitogen-activated protein kinase and that phosphorylation at the motif is required for DYRK activity. In this study, the role of tyrosine phosphorylation in the activity of DYRK1A was investigated in detail. Wild-type DYRK1A with a reduced level of phosphotyrosine (pY) was prepared by treating E. coli-produced DYRK1A with two different protein tyrosine phosphatases. The resulting pY-depleted DYRK1A could not regain pY during autophosphorylation but was as active as the untreated control. These findings were further supported by the observation that DYRK1A retained significant enzymatic activity when both tyrosine residues in the YXY motif were replaced with either histidine or glutamine. Together, we conclude that tyrosine phosphorylation and tyrosine residues in the YXY motif are not directly involved in DYRK1A enzymatic activity in vitro.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17536841     DOI: 10.1021/bi700251n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A).

Authors:  Tatyana Adayev; Jerzy Wegiel; Yu-Wen Hwang
Journal:  Arch Biochem Biophys       Date:  2010-12-24       Impact factor: 4.013

2.  Effects of Y361-auto-phosphorylation on structural plasticity of the HIPK2 kinase domain.

Authors:  Antonella Scaglione; Laura Monteonofrio; Giacomo Parisi; Cristina Cecchetti; Francesca Siepi; Cinzia Rinaldo; Alessandra Giorgi; Daniela Verzili; Carlotta Zamparelli; Carmelinda Savino; Silvia Soddu; Beatrice Vallone; Linda Celeste Montemiglio
Journal:  Protein Sci       Date:  2017-12-28       Impact factor: 6.725

Review 3.  Human Protein Reference Database and Human Proteinpedia as resources for phosphoproteome analysis.

Authors:  Renu Goel; H C Harsha; Akhilesh Pandey; T S Keshava Prasad
Journal:  Mol Biosyst       Date:  2011-12-08

4.  MiR-1246: a new link of the p53 family with cancer and Down syndrome.

Authors:  Jun-Ming Liao; Xiang Zhou; Yu Zhang; Hua Lu
Journal:  Cell Cycle       Date:  2012-07-15       Impact factor: 4.534

5.  Intracellular distribution of differentially phosphorylated dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A).

Authors:  Wojciech Kaczmarski; Madhabi Barua; Bozena Mazur-Kolecka; Janusz Frackowiak; Wieslaw Dowjat; Pankaj Mehta; David Bolton; Yu-Wen Hwang; Ausma Rabe; Giorgio Albertini; Jerzy Wegiel
Journal:  J Neurosci Res       Date:  2013-11-22       Impact factor: 4.164

6.  Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I: A MOLECULAR MECHANISM LINKED TO TAU PATHOLOGY IN ALZHEIMER DISEASE.

Authors:  Nana Jin; Xiaomin Yin; Jianlan Gu; Xinhua Zhang; Jianhua Shi; Wei Qian; Yuhua Ji; Maohong Cao; Xiaosong Gu; Fei Ding; Khalid Iqbal; Cheng-Xin Gong; Fei Liu
Journal:  J Biol Chem       Date:  2015-04-27       Impact factor: 5.157

7.  Phosphorylation by Dyrk1A of clathrin coated vesicle-associated proteins: identification of the substrate proteins and the effects of phosphorylation.

Authors:  Noriko Murakami; David C Bolton; Elizabeth Kida; Wen Xie; Yu-Wen Hwang
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

8.  Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition.

Authors:  Meera Soundararajan; Annette K Roos; Pavel Savitsky; Panagis Filippakopoulos; Arminja N Kettenbach; Jesper V Olsen; Scott A Gerber; Jeyanthy Eswaran; Stefan Knapp; Jonathan M Elkins
Journal:  Structure       Date:  2013-05-09       Impact factor: 5.006

9.  Identification of a DYRK1A Inhibitor that Induces Degradation of the Target Kinase using Co-chaperone CDC37 fused with Luciferase nanoKAZ.

Authors:  Rie Sonamoto; Isao Kii; Yuka Koike; Yuto Sumida; Tomoe Kato-Sumida; Yukiko Okuno; Takamitsu Hosoya; Masatoshi Hagiwara
Journal:  Sci Rep       Date:  2015-08-03       Impact factor: 4.379

10.  HIPK2 catalytic activity and subcellular localization are regulated by activation-loop Y354 autophosphorylation.

Authors:  Francesca Siepi; Veronica Gatti; Serena Camerini; Marco Crescenzi; Silvia Soddu
Journal:  Biochim Biophys Acta       Date:  2013-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.